Multiple beneficial actions of fructose 1,6-biphosphate in sepsis-associated liver injury.
Muntané
Jordi
J
D000818:Animals; D005635:Fructosediphosphates / Q000494:pharmacology*; D022781:Hepatocytes / Q000187:drug effects; D007155:Immunologic Factors / Q000494:pharmacology*; D007728:Kupffer Cells / Q000187:drug effects; D017114:Liver Failure, Acute / Q000188:drug therapy* / Q000503:physiopathology; D008262:Macrophage Activation / Q000187:drug effects; D015221:Potassium Channels / Q000187:drug effects; D018805:Sepsis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects
D005635:Fructosediphosphates; D007155:Immunologic Factors; D015221:Potassium Channels; D014409:Tumor Necrosis Factor-alpha; C029063:fructose-1,6-diphosphate